Table 1

Clinical and laboratory data of the patients at the time of study
Patient Number
 Age
 Gender
 ANCA Titre
 Clinical Status
 Treatment
 Organ Involvement
1
 37
 M
 PR3 60 U
 Remission
 Nil
 R, J
2
 69
 M
 PR3 34 U
 Newly Diagnosed
 Prednisolone 5 mg/day
 R, J
3
 56
 M
 PR3 >100 U
 Relapse
 Nil
 R, J, S, P
4
 73
 F
 PR3 >100 U
 Newly Diagnosed
 Nil
 R, L, E
5
 50
 M
 PR3 33 U
 Newly Diagnosed
 Nil
 L, E, J
6
 63
 M
 MPO >100 U
 Newly Diagnosed
 Nil
 R, L, C, J
7
 77
 M
 MPO 54 U
 Newly Diagnosed
 Nil
 R, L
8
 67
 M
 MPO 38 U
 Relapse
 Nil
 R, L
9
 57
 M
 MPO 47U
 Relapse
 Nil
 R, S, L
10
 82
 M
 MPO >100 U
 Newly Diagnosed
 Nil
 R, J

R = Renal, E = ENT, L = Lung, C = Cardiac, J = Joints, S = Skin, P = Peripheral Neuropathy

Hurtado et al. BMC Immunology 2008 9:34   doi:10.1186/1471-2172-9-34